|
Nach Börsenschluss USA bereits 16% plus Encysive Pharmaceuticals Inc. has added a news release to its Investor Relations website. Title: Encysive Pharmaceuticals Receives FDA Clearance to Resume Clinical Studies With TBC3711 Date: 12/7/2006 6:45:15 PM For a complete listing of our news releases, please click here |
|
| aus der Diskussion: | 42% Plus Ency und die Thelin (TM) Story |
| Autor (Datum des Eintrages): | kaktus10 (08.12.06 01:21:18) |
| Beitrag: | 7 von 12 (ID:26011429) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |